The endogenous cannabinoid anandamide shares discriminative stimulus effects with △9-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice

European Journal of Pharmacology

Volumn 656, Issue 1-3, 2011, Pages 63-67

  Walentiny, D Matthew ^a   Gamage, Thomas F ^a   Warner, Jonathan A ^a   Nguyen, Thanh K ^a   Grainger, Darren B ^a   Wiley, Jenny L ^a,b   Vann, Robert E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

9 tetrahydrocannabinol; Anandamide; Drug discrimination; Fatty acid amide hydrolase; Knockout mice; Marijuana

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; DRONABINOL; FATTY ACID AMIDASE; OLEAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; ENZYME ACTIVITY; FATTY ACID METABOLISM; INTOXICATION; KNOCKOUT MOUSE; MALE; MENTAL TASK; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; DISCRIMINATION (PSYCHOLOGY); GENE KNOCKOUT TECHNIQUES; MALE; MICE; OLEIC ACIDS; POLYUNSATURATED ALKAMIDES; TETRAHYDROCANNABINOL;

EID: 79952280874     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.01.056     Document Type: Article

References (42)

1. V. Abadji, S. Lin, G. Taha, G. Griffin, L.A. Stevenson, R.G. Pertwee, and A. Makriyannis (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability J. Med. Chem. 37 1994 1889 1893 (Pubitemid 24219781)
2. R.L. Balster, and W.R. Prescott Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication Neurosci. Biobehav. Rev. 16 1992 55 62
3. A.S. Basile, L. Hanus, and W.B. Mendelson Characterization of the hypnotic properties of oleamide NeuroReport 10 1999 947 951 (Pubitemid 29317970)
4. R.T. Burkey, and J.R. Nation (R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure Exp. Clin. Psychopharmacol. 5 1997 195 202 (Pubitemid 27346444)
5. S.R. Childers, T. Sexton, and M.B. Roy Effects of anandamide on cannabinoid receptors in rat brain membranes Biochem. Pharmacol. 47 1994 711 715 (Pubitemid 24094276)
6. F.C. Colpaert Drug discrimination in neurobiology Pharmacol. Biochem. Behav. 64 1999 337 345 (Pubitemid 29438619)
7. B.F. Cravatt, D.K. Giang, S.P. Mayfield, D.L. Boger, R.A. Lerner, and N.B. Gilula Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87 (Pubitemid 26374593)
8. B.F. Cravatt, K. Demarest, M.P. Patricelli, M.H. Bracey, D.K. Giang, B.R. Martin, and A.H. Lichtman Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proc. Natl Acad. Sci. USA 98 2001 9371 9376 (Pubitemid 32743923)
9. J.N. Crawley, R.L. Corwin, J.K. Robinson, C.C. Felder, W.A. Devane, and J. Axelrod Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents Pharmacol. Biochem. Behav. 46 1993 967 972
10. V. Di Marzo, L. De Petrocellis, and T. Bisogno The biosynthesis, fate and pharmacological properties of endocannabinoids Handb. Exp. Pharmacol. 2005 147 185
11. Y. Gaoni, and R. Mechoulam Isolation, structure and partial synthesis of an active constituent of hashish J. Am. Chem. Soc. 86 1964 1646 1647
12. B.G. Henriksson, J.O. Johansson, and T.U. Jarbe Delta 9-tetrahydrocannabinol produced discrimination in pigeons Pharmacol. Biochem. Behav. 3 1975 771 774
13. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, W.A. Devane, C.C. Felder, M. Herkenham, K. Mackie, B.R. Martin, R. Mechoulam, and R.G. Pertwee International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol. Rev. 54 2002 161 202 (Pubitemid 34575709)
14. T.U. Jarbe, J.O. Johansson, and B.G. Henriksson Delta9- tetrahydrocannabinol and pentobarbital as discriminative cues in the Mongolian Gerbil (Meriones unguiculatus) Pharmacol. Biochem. Behav. 3 1975 403 410
15. T.U. Jarbe, R.J. Lamb, A. Makriyannis, S. Lin, and A. Goutopoulos Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats Psychopharmacology (Berl) 140 1998 519 522 (Pubitemid 28566852)
16. T.U. Jarbe, R.J. Lamb, S. Lin, and A. Makriyannis Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication Behav. Pharmacol. 11 2000 81 86 (Pubitemid 30223761)
17. T.U. Jarbe, R.J. Lamb, S. Lin, and A. Makriyannis (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide Psychopharmacology (Berl) 156 2001 369 380 (Pubitemid 32695845)
18. J.D. Leggett, S. Aspley, S.R. Beckett, A.M. D'Antona, and D.A. Kendall Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors Br. J. Pharmacol. 141 2004 253 262 (Pubitemid 38250895)
19. A.H. Lichtman, E.G. Hawkins, G. Griffin, and B.F. Cravatt Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo J. Pharmacol. Exp. Ther. 302 2002 73 79 (Pubitemid 34680423)
20. A.H. Lichtman, C.C. Shelton, T. Advani, and B.F. Cravatt Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia Pain 109 2004 319 327 (Pubitemid 38638709)
21. J.Z. Long, D.K. Nomura, R.E. Vann, D.M. Walentiny, L. Booker, X. Jin, J.J. Burston, L.J. Sim-Selley, A.H. Lichtman, J.L. Wiley, and B.F. Cravatt Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo Proc. Natl Acad. Sci. USA 106 2009 20270 20275
22. L.R. McMahon Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol Psychopharmacology (Berl) 203 2009 219 228
23. L.R. McMahon, B.C. Ginsburg, and R.J. Lamb Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice Psychopharmacology (Berl) 198 2008 487 495 (Pubitemid 351754667)
24. R. Mechoulam, E. Fride, L. Hanus, T. Sheskin, T. Bisogno, V. Di Marzo, M. Bayewitch, and Z. Vogel Anandamide may mediate sleep induction Nature 389 1997 25 26 (Pubitemid 27387679)
25. R.A. Ross Anandamide and vanilloid TRPV1 receptors Br. J. Pharmacol. 140 2003 790 801 (Pubitemid 37464060)
26. P.B. Smith, D.R. Compton, S.P. Welch, R.K. Razdan, R. Mechoulam, and B.R. Martin The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice J. Pharmacol. Exp. Ther. 270 1994 219 227 (Pubitemid 24229631)
27. M. Solinas, M. Scherma, G. Tanda, C.E. Wertheim, W. Fratta, and S.R. Goldberg Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide J. Pharmacol. Exp. Ther. 321 2007 1127 1134 (Pubitemid 46762677)
28. M. Solinas, G. Tanda, Z. Justinova, C.E. Wertheim, S. Yasar, D. Piomelli, S.K. Vadivel, A. Makriyannis, and S.R. Goldberg The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport J. Pharmacol. Exp. Ther. 321 2007 370 380 (Pubitemid 46456957)
29. R.E. Vann, C.D. Cook, B.R. Martin, and J.L. Wiley Cannabimimetic properties of ajulemic acid J. Pharmacol. Exp. Ther. 320 2007 678 686 (Pubitemid 46147948)
30. R.E. Vann, J.A. Warner, K. Bushell, J.W. Huffman, B.R. Martin, and J.L. Wiley Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice Eur. J. Pharmacol. 615 2009 102 107
31. S.A. Varvel, B.F. Cravatt, A.E. Engram, and A.H. Lichtman Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task J. Pharmacol. Exp. Ther. 317 2006 251 257
32. S.A. Varvel, L.E. Wise, F. Niyuhire, B.F. Cravatt, and A.H. Lichtman Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task Neuropsychopharmacology 32 2007 1032 1041 (Pubitemid 46631982)
33. D.M. Walentiny, R.E. Vann, J.A. Warner, L.S. King, H.H. Seltzman, H.A. Navarro, C.E. Twine Jr., B.F. Thomas, A.F. Gilliam, B.P. Gilmour, F.I. Carroll, and J.L. Wiley Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents Psychopharmacology (Berl) 210 2010 275 284
34. J.L. Wiley Cannabis: discrimination of "internal bliss"? Pharmacol. Biochem. Behav. 64 1999 257 260
35. J.L. Wiley, R.L. Balster, and B.R. Martin Discriminative stimulus effects of anandamide in rats Eur. J. Pharmacol. 276 1995 49 54
36. J.L. Wiley, R.L. Barrett, J. Lowe, R.L. Balster, and B.R. Martin Discriminative stimulus effects of CP 55, 940 and structurally dissimilar cannabinoids in rats Neuropharmacology 34 1995 669 676
37. J.L. Wiley, K.M. Golden, W.J. Ryan, R.L. Balster, R.K. Razdan, and B.R. Martin Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys Pharmacol. Biochem. Behav. 58 1997 1139 1143 (Pubitemid 28108227)
38. J.L. Wiley, W.J. Ryan, R.K. Razdan, and B.R. Martin Evaluation of cannabimimetic effects of structural analogs of anandamide in rats Eur. J. Pharmacol. 355 1998 113 118 (Pubitemid 28404692)
39. J.L. Wiley, K.L. LaVecchia, N.E. Karp, S. Kulasegram, A. Mahadevan, R.K. Razdan, and B.R. Martin A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats Exp. Clin. Psychopharmacol. 12 2004 173 179 (Pubitemid 38988713)
40. J.L. Wiley, J.J. Burston, D.C. Leggett, O.O. Alekseeva, R.K. Razdan, A. Mahadevan, and B.R. Martin CB1 cannabinoid receptor-mediated modulation of food intake in mice Br. J. Pharmacol. 145 2005 293 300 (Pubitemid 40896074)
41. L.E. Wise, C.C. Shelton, B.F. Cravatt, B.R. Martin, and A.H. Lichtman Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors Eur. J. Pharmacol. 557 2007 44 48 (Pubitemid 46135555)
42. L.E. Wise, R. Cannavacciulo, B.F. Cravatt, B.F. Martin, and A.H. Lichtman Evaluation of fatty acid amides in the carrageenan-induced paw edema model Neuropharmacology 54 2008 181 188 (Pubitemid 350299403)